As of Jan 20
| +0.03 / +0.18%|
The 5 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 17.50. The median estimate represents a +6.89% increase from the last price of 16.84.
The current consensus among 6 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.